PubMed Health⌕ Search

Biomedical subjects

David J Callans

Publications and source records attributed to David J Callans.

At least 55 records · Page 3Linked to original sources

Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography.

OBJECTIVES: This study reports the incidence of, risk factors for, and management of left atrial (LA) thrombus documented by intracardiac echocardiography (ICE) during LA ablation for atrial fibrillation (AF). BACKGROUND: Thrombus formation is a risk associated with LA ablation procedures. METHODS: Intracardiac echocardiography imaging was performed in 232 patients (184 men, average age 55 +/- 11 years) with AF undergoing pulmonary vein ostial ablation. RESULTS: Anticoagulation (activated clotting time >250 s) was maintained after dual transseptal catheterization. Left atrial thrombus (n = 30) was observed in 24 of 232 patients (10.3%). Thrombi measured 12.9 +/- 11.1 mm (length) and 2.2 +/- 1.3 mm (width) and were attached to a sheath or mapping catheter. Most thrombi (27 of 30, 90%) were eliminated from the LA by withdrawal of the sheath and catheter into the right atrium (RA). Two thrombi became wedged in the interatrial septum and incompletely withdrawn into the RA, and one was recognized only on post-procedure review of ICE images. Patients with LA thrombus had an increased LA diameter (4.8 +/- 0.5 vs. 4.5 +/- 0.6 cm, p < 0.02), spontaneous echo contrast (67% vs. 3%, p < 0.0001) and a history of persistent AF (29% vs. 6%, p < 0.0002). Multivariate discriminant analysis showed that spontaneous echo contrast (f = 97.9, p < 0.0001) was the most important determinant of LA thrombus formation. No patient with LA thrombus suffered a clinical thromboembolic complication. CONCLUSIONS: Left atrial thrombus identified on ICE may occur during LA catheter ablation procedures despite aggressive anticoagulation. Spontaneous echo contrast may predict risk for LA thrombus formation. Left atrial thrombus may be successfully withdrawn into the RA under ICE imaging with no overt complications.

Adolescent↗

Favorable effect of pulmonic vein isolation by partial circumferential ablation on ostial flow velocity.

OBJECTIVES: The aim of this study was to determine the effect of electrical isolation of pulmonic vein (PV) on flow velocity. BACKGROUND: We report our experience with electrical isolation of PV by partial circumferential ablation and its effect on ostial peak flow velocity as assessed by phased-array ultrasound catheter imaging. METHODS: Sixty-two patients participated in the study. Magnetic electroanatomic mapping, ultrasound catheter imaging, and Lasso mapping catheter were used. Electrical isolation was achieved by delivering radiofrequency ablation (RFA) lesions proximal to Lasso mapping catheter bipoles showing PV entry. Following this, the number of RFA lesions/PV and their segment-wise distribution (maximum 4/PV) were assessed. RESULTS: Fifty right superior, 51 left superior, 32 left inferior, and 17 right inferior PVs were isolated. RFA involved 4 segments in 42 PVs, 3 segments in 61 PVs, and </=2 segments in 47 PVs. Electrical isolation augmented ostial peak flow velocity (55 +/- 15 cm/s to 96 +/- 26 cm/s). This net increase was higher for superior versus inferior PVs (43 +/- 23 cm/s and 34 +/- 18 cm/s; P = .02). For </=2, 3, and 4 segments ablated per vein, the net increase in peak flow velocity was 33 +/- 22 cm/s, 42 +/- 23 cm/s, and 46 +/- 23 cm/s, respectively (P = .02). Over a mean follow-up of 16 +/- 7 months, freedom from atrial fibrillation (AF) or >90% reduction in AF burden, either with or without previously ineffective antiarrhythmic agents, was achieved in 54 patients (87%). CONCLUSIONS: In the majority of PVs (72%), electrical isolation can be achieved by partial circumferential ablation (targeting </=3 segments/PV) with lower acute increase in ostial peak flow velocity and good AF control.

Adult↗

Effect of heart rate and isoproterenol on pulmonary vein flow velocity following radiofrequency ablation: a Doppler color flow imaging study.

INTRODUCTION: Application of radiofrequency energy at pulmonary vein (PV) ostium during focal atrial fibrillation (AF) ablation procedures increases flow velocity due to PV narrowing. Factors unrelated to ablation that effect PV flow velocity have not been described. AIMS OF THE STUDY: The purpose of this study was to evaluate, using intracardiac echocardiography (ICE) imaging, the effect of isoproterenol (ISO) and heart rate (HR) on PV flow velocity Pre- and Post-ablation. METHODS AND RESULTS: In 31 patients with AF undergoing LA-PV ostial ablation involving at least one PV ostium, an ICE catheter was placed in the RA to image and detect PV flow. PV ostial peak velocity was assessed in sinus rhythm Pre-, Post-ablation, during and after ISO (up to 20 microg/min). To separate HR versus ISO effect, PV velocity was measured during atrial pacing (after HR returned to baseline) at pacing rate matching HR with ISO. PV ostial velocity was assessed with ISO and pacing in 30 non-ablated and 33 ablated PVs. Ostial velocities of non-ablated PVs during ISO infusion (117 +/- 42 cm/s) were greater ( p < 0.03) than those during atrial pacing (78 +/- 26 cm/s) at matched HR (116 +/- 20, range 92-150 bpm). Ostial PV flow velocities of ablated PVs increased from 59 +/- 17 (30-95) cm/s Pre- to 95 +/- 25 (58-136) cm/s Post-ablation. During ISO infusion PV flow velocities in ablated PVs (118 +/- 34 cm/s) were also greater ( p < 0.03) than those during atrial pacing (96 +/- 37 cm/s) at matched HR (116 +/- 14, range 92-130 bpm). Atrial pacing alone produced no significant difference in PV flow velocities measured Pre- or Postablation. CONCLUSION: ISO appears to increase ostial flow velocity of ablated and non-ablated PVs independent of HR effect. These effects are important to recognize when PV velocity is used as an index for interpreting the impact of PV ostial lesions on functionally significant PV narrowing.

Adrenergic beta-Agonists↗

Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation.

INTRODUCTION: Pulmonary vein (PV) isolation is effective in the treatment of most patients with atrial fibrillation (AF). Some advocate the addition of linear ablation techniques to improve efficacy; however, previous studies suggest recurrent PV conduction is responsible for AF recurrence. The aim of this study was to determine the effectiveness of repeat PV isolation in patients with recurrent AF after an initial ablation procedure and to determine if any patient characteristics predict failure of repeat PV isolation procedures. METHODS AND RESULTS: Seventy-four patients with two or more AF ablation procedures using selective PV isolation were included. PV isolation was guided with multielectrode ring catheter recordings, electroanatomic mapping, and intracardiac electrocardiography. Radiofrequency energy was delivered using a 4-mm-tip catheter (maximum 40 W, 52 degrees C); cooled-tip ablation was performed in 10 patients. Linear ablation was not performed. Antiarrhythmic drugs were continued for at least 6 weeks after ablation; AF episodes during this period were censored. Reconnection of one or more segments of previously ablated PVs was observed in 97% of patients; reconnected PVs served as the trigger for AF in 77%. Repeat PV isolation resulted in AF control (cure or 90% reduction in AF episodes) in 64 patients (86%) over a follow-up period of 9.1 +/- 6.7 months. "High-risk" characteristics such as left atrial enlargement, persistent AF, or mitral regurgitation did not predict failure of repeat PV isolation procedures. CONCLUSION: Recurrent AF following selective PV isolation is overwhelmingly associated with PV electrical reconnection. Repeat PV isolation without linear ablation provides effective treatment for recurrent AF in patients in whom an initial PV isolation procedure failed, independent of clinical characteristics.

Atrial Fibrillation↗

ECG criteria for localizing the pulmonary vein origin of spontaneous atrial premature complexes: validation using intracardiac recordings.

We have shown that pacemapping from each of the pulmonary veins reveals unique surface ECG characteristics. However, application of these criteria to spontaneous atrial premature complexes is often difficult because of obscuration by the prior T wave. We hypothesized that the pulmonary vein of origin of spontaneous atrial premature complexes can be determined by measuring characteristics of the P wave whether or not the P wave was superimposed on the prior T wave. We analyzed 58 spontaneous atrial premature complexes of known pulmonary vein origin in 30 patients referred for atrial fibrillation ablation. The origin of all the atrial premature complexes was documented by detailed, intracardiac multipolar catheter mapping. Based on previous work, the criteria for distinguishing right-sided from left-sided pulmonary vein origin of atrial premature complex includes: (1) P wave duration < 120 ms; (2) P wave amplitude in lead I > 0.05 mV; and (3) P wave amplitude in leads II/III > 1.25. The criteria to separate superior from inferior pulmonary veins included the sum of the P wave amplitude in all the inferior leads greater than 0.3 mV. The combination of the P wave duration < 120 ms and the ratio of the P wave amplitude in leads II/III > 1.25, distinguished right-sided from left-sided pulmonary vein origin of spontaneous atrial premature complexes with a sensitivity of 82% and specificity of 100%. The sum of the P wave amplitude in leads II, III, and aVF > 0.3 mV distinguished superior from inferior pulmonary vein of origin with a sensitivity of 39% and specificity of 73%. The pulmonary vein origin of spontaneous atrial premature complexes can often be localized using careful quantitative analysis of the surface ECG despite superimposition of the P wave upon the T wave. Separation of right-sided from left-sided pulmonary vein origin of spontaneous atrial premature complexes can be determined with good specificity and sensitivity, while the ability to distinguish inferior from superior pulmonary vein origin is limited.

Atrial Fibrillation↗

Mechanisms underlying sustained firing from pulmonary veins: evidence from pacing maneuvers and pharmacological manipulation.

Atrial Fibrillation (AF) is often initiated by pulmonary vein (PV) depolarizations. However, sustained PV firing (PVF) is infrequently observed in this population and has not been characterized. In 15 patients undergoing AF ablation we report the response of sustained PVF to pacing and pharmacological maneuvers. Sustained PVF was defined as discrete, repetitive, electrical activity during sinus rhythm that did not correspond with other electrical events (P, QRS, T wave), persisting > or =5 minutes and recorded at/or distal to PV ostium prior to ablation. During sustained PVF, pacing was performed from coronary sinus and/or posterior right atrium at different cycle lengths (900 to 400 ms; duration: 30 to 60 s) following which, if PVF persisted, in random order, isoproterenol and adenosine were administered and carotid sinus massage (CSM) was performed. PVF response was classified as: suppressed (complete quiescence), augmented (increase in frequency of PVF/AF initiation) and "no effect." Sustained PVF was observed in 16 veins. In 13 (81%) patients, PVF was suppressed during overdrive pacing with early recurrence (< or =5 s) postpacing regardless of pacing cycle length in 11 (85%) patients. PVF was augmented by isoproterenol in the majority of patients (88%) and showed mixed response to adenosine (augmented 40%, suppressed 20%, and no effect 40%). CSM appeared to have no effect on PVF in the majority of patients (86%). Sustained PVF is seen infrequently in patients undergoing AF ablation. Its response to pacing maneuvers argues against sustained reentry and supports triggered activity and/or abnormal automaticity as the mechanisms underlying the phenomenon.

Adenosine↗

Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia.

BACKGROUND: Although catheter mapping has been used to define the endocardial electrogram characteristics in patients with ventricular tachycardia (VT) and coronary disease, characterization of the electrophysiological substrate in patients with VT and nonischemic cardiomyopathy is limited. METHODS AND RESULTS: Left ventricular endocardial electroanatomical mapping was performed in 19 patients with nonischemic cardiomyopathy and monomorphic VT with an average of 178+/-83 sites per chamber mapped. Abnormal bipolar electrogram was defined as endocardial voltage signal amplitude of <1.8 mV. The extent and location of abnormal endocardium was estimated by measuring areas of abnormal electrogram recordings from 3D voltage maps. The origin of VT was approximated by identifying sites of entrainment with concealed fusion or early presystolic activity and/or by pace mapping. Abnormal electrograms were recorded over a 41+/-28 cm2 area that represented 20+/-12% of total endocardial surface. The majority of patients (14/19 patients) had only a modest area (<25%) of endocardial abnormality. All patients had abnormal low-voltage endocardial areas located near the ventricular base in the perivalvular region. There were 3+/-1 VT morphologies per patient. The majority (88%) of the 57 mapped VTs originated from the ventricular base, corresponding to regions with abnormal endocardial electrograms. CONCLUSIONS: Electroanatomical mapping in patients with monomorphic VT and nonischemic cardiomyopathy typically demonstrates a modest-sized basal area of endocardial electrogram abnormalities. The VT site of origin corresponds to these basal electrogram abnormalities. These findings have important implications regarding strategies for VT ablation in this setting.

Adult↗

Quantitative comparison of spontaneous and paced 12-lead electrocardiogram during right ventricular outflow tract ventricular tachycardia.

OBJECTIVES: The purpose of this study was to objectively quantify the similarity of 12-lead electrocardiogram (ECG) waveforms using two quantitative metrics, the correlation coefficient (CORR) and the mean absolute deviation (MAD). BACKGROUND: Comparison of the 12-lead ECG morphology between ventricular tachycardia (VT) and a pace-map is frequently performed; however, there are no objective criteria for quantifying the similarity between two waveform morphologies. METHODS: During ablation of right ventricular outflow tract (RVOT) VT, 12-lead ECG pace-maps were acquired from three superior septal sites, three superior free wall sites, and before each ablation attempt in 15 patients. The 12-lead ECG waveforms of the clinical tachycardia and pace-maps were compared using both MAD and CORR at each site. RESULTS: The MAD scores were lower (i.e., more closely matched) for septal compared with free wall sites (15.9 +/- 5.3% vs. 25.3 +/- 10.2%; p < 0.001). Successful ablation sites had a significantly lower MAD score compared with unsuccessful sites (9.5 +/- 2.8% vs. 13.3 +/- 5.6%; p = 0.01), whereas there was only a trend toward a higher CORR for successful ablation sites (98.2 +/- 1.2% vs. 96 +/- 4.7%; p = 0.07). A MAD score < or =12% was 93% sensitive and 75% specific for identifying a successful ablation site. There was an inverse correlation between MAD score and distance from the site of VT origin (r = 0.63, p < 0.001). CONCLUSIONS: A MAD score >12% between RVOT VT and a pace-map at any site suggests sufficient dissimilarity to dissuade ablation at that site. The MAD score can be used to standardize 12-lead ECG waveform morphology comparisons among different laboratories, and may be useful for guiding ablation of VT.

Adult↗

Change in distant atrial activation patterns during circumferential pacemapping of pulmonic vein ostium: implications for localizing triggers for atrial fibrillation.

INTRODUCTION: Unique intracardiac activation patterns recorded from multipolar catheters in the coronary sinus (CS) and posteromedial right atrium (RA) when pacing from ostium (os) of each pulmonic vein (PV) can serve as template for determining PV of origin of atrial premature complexes. Development of an accurate template requires knowledge of variations in activation pattern during pacing from different aspects of same PV. METHODS: In 25 patients undergoing catheter ablation for AF, a decapolar Lasso mapping catheter was placed at PV os of interest and multipolar catheters were placed in CS and RA-medial to crista terminalis (CT). For each PV, pacing was performed from Lasso catheter poles 1 through 10. For each bipole paced, activation sequence in CS (proximal to distal & vice-versa) was assessed, activation time (pacing stimulus to earliest electrogram recorded in catheters in CS/along CT) was measured and difference (CS - CT time) was determined. Significant interpolar variation was defined as the difference between the shortest and longest CS - CT activation time of >/=25 msec when pacing from different bipoles of same PV. RESULTS: In 59 PVs [19 right superior (RS), 20 left superior (LS), 8 right inferior (RI) and 12 left inferior (LI)], 259 bipoles were paced (median of 4 bipoles/PV). During circumferential PV pacing activation sequence in CS catheter was distal to proximal in 84.4% left-sided PVs (LSPV and LIPV) and proximal to distal in 92.6% right-sided PVs (RSPV and RIPV) with no change in activation sequence observed during pacing from different bipoles in same PV. Significant interpolar variation was observed with circumferential pacing in 1 of 19 RSPV (5.3%), 2 of 20 LSPV (10%), 1 of 12 LIPV (8.3%) and none of RIPV. CONCLUSION: Unique intracardiac activation patterns during ostial pacing from individual PV are not influenced by circumferential location of pacing site.

Atrial Fibrillation↗

Electrocardiographic patterns of superior right ventricular outflow tract tachycardias: distinguishing septal and free-wall sites of origin.

INTRODUCTION: The superior right ventricular outflow tract (RVOT) septum and free wall are common locations of origin for outflow tract ventricular tachycardias (VT). We hypothesized that (1) unique ECG morphologies of pace maps from septal and free-wall sites in the superior RVOT could be identified using magnetic electroanatomic mapping for accurate anatomical localization; and (2) this ECG information could help facilitate pace mapping and accurate VT localization. METHODS AND RESULTS: In 14 patients with structurally normal hearts who were undergoing ablation for outflow tract VT, a detailed magnetic electroanatomic map of RVOT was constructed in sinus rhythm, then pace mapping was performed from anterior, mid, and posterior sites along the septum and free wall of the superior RVOT. Pace maps were analyzed for ECG morphologies in limb leads and transition patterns in precordial leads. Monophasic R waves in inferior leads for septal sites were taller (1.7 +/- 0.4 mV vs 1.1 +/- 0.3 mV; P < 0.01) and narrower (158 +/- 21 msec vs 168 +/- 15 msec; P < 0.01) compared with free-wall sites; lacked "notching" (28.6% vs 95.2%; P < 0.05); and showed early precordial transition (by lead V4; 78.6% vs 4.8%; P < 0.05). A positive R wave in lead I also distinguished posterior from anterior septal and free-wall sites. Based on QRS morphology in limb leads and precordial transition pattern (early vs late), in a retrospective analysis, a blinded reviewer was able to accurately localize the site of origin of clinical arrhythmia (the successful ablation site on the magnetic electroanatomic map) in 25 of 28 patients (90%) with superior RVOT VT. CONCLUSION: Pace maps in the superior RVOT region manifest site-dependent ECG morphologies that can help in differentiating free-wall from septal locations and posterior from anterior locations. Despite overlap in QRS amplitude and duration, in the majority of patients a combination of ECG features can serve as a useful template in predicting accurately the site of origin of clinical arrhythmias arising from this region.

Adult↗

Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: implications for ablation strategies.

INTRODUCTION: The etiology of atrial fibrillation (AF) recurrences after pulmonary vein (PV) isolation is not well described. The aim of this study was to examine the reason for recurrent AF in patients undergoing a repeat attempt at AF trigger ablation. METHODS AND RESULTS: Patients with recurrent AF more than 1 month after ablation returned for repeat mapping and ablation. A circular mapping catheter was advanced to each previously targeted PV ostium to determine if the PV was still electrically isolated. Ectopy then was provoked with isoproterenol (up to 20 microg/min), burst pacing, and pacing into AF followed by cardioversion. The location of ectopy triggering atrial premature depolarizations (APDs) or AF was noted. Of 226 patients who underwent ablation of AF triggers, 34 (8 women and 26 men; age 56 +/- 10 years) with recurrent AF returned for a repeat procedure 207 +/- 183 days after the first procedure. There were 84 previously completely isolated PVs in these 34 patients. Thirty-three (39%) of 84 previously isolated PVs were still completely isolated at the time of the second procedure. Fifty-one PVs (61%) had evidence of recovered PV potentials. Fifty triggers of APDs and AF (n = 30) or APDs only (n = 20) were identified in these 34 patients. The majority of triggers [27/50 (54%)] originated from previously targeted PVs. Sixteen triggers [16/50 (32%)] originated from previously nontargeted PVs. CONCLUSION: The majority of AF recurrences originate from previously isolated PVs. One third of recurrent triggers originated from PVs that were not targeted during the initial ablation session. Although empiric isolation of all PVs may reduce recurrences, strategies to ensure ostial PV isolation and to prevent recurrent PV conduction after ablation should have the greatest impact on reducing AF recurrence.

Atrial Fibrillation↗

Left ventricular catheter ablation using direct, intramural ethanol injection in swine.

INTRODUCTION: Limitations in lesion volume and particularly lesion depth may negatively effect the efficacy of catheter ablation procedures using radiofrequency energy. This study evaluated the safety and efficacy of myocardial ablation using direct intramural injection of ethanol with a novel injection catheter system. METHODS: Left ventricular lesions were performed in 9 male swine (80-85 pounds); two animals were studied 6 weeks following anterior infarction produced by agarose gel embolization. An 8 Fr deflectable catheter equipped with a 27 gauge adjustable depth, retractable needle was directed to the LV using a retrograde aortic approach. Lesion deployment was guided by fluoroscopy and intracardiac echocardiography (ICE). Lesion characteristics were assessed with ICE imaging and pathologic analysis. RESULTS: Ethanol lesions were confined to the tissue directly adjacent to the injection port. Lesions were intramural with no evidence of overlying thrombus. Lesions delivered with a single port injection needle in normal myocardium (n = 24) averaged 1910 +/- 1066 mm(3) with a depth of 8.9 +/- 3.3 mm. Lesions directed to infarct border zones (n = 4) averaged 929 +/- 882 mm(3) with a depth of 4.3 +/- 2.8 mm. Lesions were immediately evident on ICE imaging, and were visualized by increased echo density and tissue swelling. Pathological analysis revealed homogenous lesions with intramural hemorrhage and contraction band necrosis. CONCLUSIONS: Myocardial catheter ablation using direct ethanol injection is feasible, and relatively large and deep intramural lesions can be delivered, even in the infarct border zone. This technique may prove useful in ablation of arrhythmia substrates that are deep to the endocardial surface.

Analysis of Variance↗

Mapping for ventricular tachycardia.

Mapping strategies for ventricular tachycardia (VT) have evolved significantly in the past 2 decades. This review discusses mapping techniques that can help in successful VT ablation. The electrocardiogram (ECG) remains a vital component of VT mapping and can help to identify the chamber of origin of VT. The ECG morphology of VT, however, is influenced by orientation of heart and location of the scar. Activation mapping during VT is an important technique that can help in further localization. Care has to be exercised to ensure that small signals are not ignored and far-field signals are recognized. Pace-mapping to mimic the VT is another way to map exit site for scar based reentrant VT or the site of origin of triggered and automatic VT in the absence of structural heart disease. For the latter group, this technique is widely used in determining the site of ablation. It is important to ensure a complete ECG match (12 out of 12 leads) of the pace-map to the clinical arrhythmia in these patients. In patients with structural heart disease, entrainment mapping remains the gold standard for defining the protected isthmus and other components of the VT circuit. Using this technique, successful ablation of reentrant VT can be achieved in 60-90% of patients. In order to perform entrainment mapping, the VT has to be hemodynamically tolerated; this is not the case in 25% of pts with scar based reentrant VT. The development of 3-dimensional mapping systems allows for more anatomically based linear ablation in patients with poorly tolerated uniform VT. Despite these advances, there are still about 10-20% VTs that cannot be ablated successfully with the above described techniques, especially in patients with structural heart disease. Other recent advances such as percutaneous closed chest epicardial mapping technique and cooled tip ablation catheter technology have the potential to enhance mapping and successful ablation of VT.

Body Surface Potential Mapping↗

Intracardiac Doppler echocardiographic quantification of pulmonary vein flow velocity: an effective technique for monitoring pulmonary vein ostia narrowing during focal atrial fibrillation ablation.

INTRODUCTION: Ablation at the pulmonary vein (PV) ostium to isolate triggers for atrial fibrillation (AF) may induce PV narrowing. The AcuNav ultrasound catheter can image PV flow and quantify peak velocity and may be useful in assessing the degree of narrowing of PV ostia. METHODS AND RESULTS: In 93 patients with AF undergoing PV ostial ablation (up to 40 W, 52 degrees C, 90 sec), the ultrasound catheter was placed in the right atrium and PV peak flow velocities were measured during systole and diastole before and after ablation. Ostial PV electrical isolation was achieved in 216 of the 219 targeted PVs. The ultrasound catheter provided flow imaging of all PVs. The ostial peak flow velocities measured 56 +/- 12 cm/sec before ablation and increased to 101 +/- 22 cm/sec after ablation (P < 0.001). Peak velocity >100 cm/sec was detected in 103 (47%) of 219 and > or = 158 cm/sec (estimated pressure gradient 10 mmHg) with turbulent flow features, in 7 (3.2%) of 219 PVs. The highest velocity detected in one PV was 211 cm/sec (17.7 mmHg). Follow-up ultrasound catheter measurements were obtained in 13 patients (30 previously ablated PVs) during repeat ablations. The ostial peak velocity had decreased by 22 +/- 14 cm/sec and in 25 (83%) of 30 PVs was within the baseline range (<100 cm/sec) at a mean follow-up of 4.9 +/- 2.2 months. Follow-up magnetic resonance imaging (MRI) or contrast-enhanced CT was obtained at 7.0 +/- 3.8 months in seven patients with PV velocity > 158 cm/sec after initial ablation. No significant stenosis (<30%) was identified, and no patient suffered clinical symptoms (follow-up 6-18 months) related to the described acute changes in PV flow after an initial ablation procedure. Of 13 patients with repeat ablation, two had PV velocities >100 cm/sec before repeat ablation, and three PVs in two patients had flow velocity >158 cm/sec after repeat ablation. One of these patients developed symptoms of exertional dyspnea; MRI at 4 months showed 50% to 60% ostial narrowing. CONCLUSION: Ostial ablation for PV isolation may induce a mild-to-moderate increase in PV flow velocity, which can be identified using an ultrasound catheter with Doppler color flow imaging. Increases in PV flow velocity (<158 cm/sec) after a primary ablation procedure appear to be well tolerated, and a return toward baseline flow characteristics should be anticipated by 3 months. A more cautious approach may be required for patients undergoing repeat PV isolation.

Atrial Fibrillation↗